MRFR@Press Releases

The report for  global breast cancer market   of  Market Research Future   comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.  The global breast cancer market is expected to grow at a CAGR of 9.2% during forecasted period 2017-2023. Brest cancer is type of cancer developed in breast tissue. Formation of lump in a breast, red patches on the skin are the some of the common symptoms of the breast cancer. Obesity, lack of physical exercise, overexposure to radiation and drinking alcohol are some of the risk factor for developing breast cancer. According to WHO, it is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide and this number is continuously increasing. Prevalence of breast cancer is more common in developed countries compare with developing cou

The report for  Global  Stroke Disorder & Treatment Market  of  Market Research Future  comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. Globally the market for stroke disorder & treatmentis increasing rapidly.The major factor that derives the growth of stroke disorder & treatment is the increasing high blood pressure patients. Furthermore increasing alcoholism and patients with diabetes, cardiovascular diseases are increasing the growth of Stroke Disorder & Treatmentmarket. Globally the market for Stroke Disorder & Treatmentmarket is expected to grow at the rate of about XX% CAGR from 2016 to 2022. Key Players for Stroke Disorder & Treatment Market :                                 Some of the key players in this market are:AstraZeneca (U.K), Pfizer (U.S), Bayer Pharma A

The report for Global Rheumatoid Arthritis Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. Globally the market for rheumatoid arthritis market is expected to grow at the rate of about XX% CAGR from 2016 to 2022. Globally the market for rheumatoid arthritis is increasing rapidly. The major factor that derives the growth of rheumatoid arthritis is the increasing aging population. Furthermore some evidence suggests that people who smoke are at an increased risk of developing rheumatoid arthritis. Get Sample Copy at https://www.marketresearchfuture.com/sample_request/1658 . Key Players for Rheumatoid Arthritis Market:  Pfizer Inc (U.S), Eli Lilly and company (U.S), Bristol-Myers Squibb Company (U.S), F. Hoffmann-La Roche Ltd (switzerland), Novartis AG (switzerl

The report for Global Health Supplements market  of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. Health supplements are the products which are intended to provide nutrients which may not be embedded into the body by regular diets. These supplements are generally inclusive of vitamins, fibers, minerals, fatty acids and fiber. The global Health Supplements market is expected to reach US$ by the end of the forecasted period and is expected to grow at a CAGR Get Sample Copy at https://www.marketresearchfuture.com/sample_request/1646 . Key Players for Health Supplements Market : Amway (US), Danone (France), Bayer Pharma AG (Germany), BASF SE (Germany), Glanbia plc (Republic of Ireland), Nestlé (Switzerland), Yakult Danone India Pvt Ltd, Solgar Inc. (US), BSN (US), Globa

Global Ventilator-associated pneumonia (VAP) market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. Market Scenario: Ventilator-associated pneumonia (VAP) is pneumonia that generates 48 hours or more after mechanical ventilation and is given by method of endotracheal tube or tracheostomy. Ventilator-associated pneumonia (VAP) results of the intrusion of the lower respiratory tract and lung parenchyma by micro organisms. The global market for Ventilator-associated pneumonia (VAP) is expected to reach US$ XX by the end of the forecasted period and is expected to grow at a CAGR of XX% Get Sample copy at https://www.marketresearchfuture.com/sample_request/1377 . Key Players for Ventilator-associated pneumonia (VAP) Market: Merck & Co., Inc. (US), Adenium Biotech A